Gilead CEO Executes $17.3M Share Sale, Exercises Options as Analysts Lift Targets
Gilead Sciences CEO Daniel Patrick O’Day sold 115,640 shares of common stock on February 5, 2026, at $150.00 per share, receiving $17,346,000, and simultaneously exercised options to acquire the same number of shares at $66.01 for a value of $7,633,396. The transactions were carried out under a Rule 10b5-1 trading plan adopted February 28, 2025. Se…